1.
Expanded 2026 ADA Guidance on SGLT2i in CKD Starting at eGFR ≥20 and combining with a nonsteroidal MRA. d. 2026;4(17):34-35. Accessed July 28, 2026. https://thediabzen.com/index.php/d/article/view/60